Ashley Odukoya
Family Medicine · San Francisco, CANPI 1225554033
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 138 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations.
Across 138 payments — averaging $13.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$444
- AbbVie$353
- Lilly USA, LLC$198
- Bayer$143
- Biohaven Pharmaceutical Holding Company Ltd.$97
- AstraZeneca$96
- plus $541 from 14 others
What the payments were for
- Food & beverage$1,873100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 37 | $444 |
| AbbVie | 31 | $353 |
| Lilly USA, LLC | 13 | $198 |
| Bayer | 7 | $143 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $97 |
| AstraZeneca | 7 | $96 |
| Boehringer Ingelheim | 6 | $86 |
| Pfizer | 5 | $77 |
| GSK | 5 | $72 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $42 |
| Exact Sciences | 2 | $42 |
| Amgen | 3 | $41 |
| Merck | 3 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Novartis | 2 | $28 |
| Amarin Pharma, Inc. | 2 | $26 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$1,873 in reported general payments places this provider in the 80th percentile of 10,533 family medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trazodone Hcl | 14 | $397 |
| Atorvastatin Calcium | 27 | $372 |
| Rosuvastatin Calcium | 14 | $238 |
| Pravastatin Sodium | 14 | $222 |
| Omeprazole | 20 | $194 |
| Amlodipine Besylate | 36 | $177 |
| Metformin Hcl | 11 | $123 |
| Baclofen | 11 | $81 |
| Losartan Potassium | 11 | $65 |
| Sumatriptan Succinate | 13 | $56 |
Paid to pharmacies, not to this prescriber.
Other family medicine in San Francisco
- Nasser MohamedSan Francisco$278K
- Colleen RileySan Francisco$115K
- Konstantin BukovSan Francisco$75K
- Sherly SoleimanEncino$1.2M
- Pamela KushnerLos Angeles$1.2M
- Sujata NarayanStanford$1.2M
- Jeffrey UngerChino$906K
- Alexander RivkinLos Angeles$866K
- Scott HowellLos Angeles$793K
- Derrick ButlerLos Angeles$692K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.